Estradiol Valerate Injection

[25 January 2017]

Products Affected - Description

Delestrogen injection, Par Sterile Products
10 mg/mL, 5 mL vial, 1 count (NDC 42023-0110-01)
20 mg/mL, 5 mL vial, 1 count (NDC 42023-0111-01)
40 mg/mL, 5 mL vial, 1 count (NDC 42023-0112-01)
Estradiol valerate injection, Perrigo
40 mg/mL, 5 mL vial, 1 count (NDC 00574-0872-05)

Reason for the Shortage

  • Par states the reason for the shortage is manufacturing delay.
  • Perrigo states the reason for the shortage is manufacturing issues.

Available Products

Estradiol valerate injection, Perrigo
20 mg/mL, 5 mL vial, 1 count (NDC 00574-0870-05)

Estimated Resupply Dates

  • Par Sterile Products has Delestrogen 10 mg/mL 5 ml vials, 20 mg/mL 5 mL vials, and 40 mg/mL 5 mL vials on back order and the company estimates a release date of late-March 2017.
  • Perrigo has estradiol valerate 40 mg/mL 5 mL vials on intermittent back order and the company is releasing product as it becomes available.

Related Shortages


January 25, 2017; December 13, November 22 and 1, August 5, July 20, June 7, May 24, April 11, January 29, 2016; December 1, November 24, September 21 and 9, June 17, 2015, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
ASHP Product Listing